Tara Semb | CFO, Treasurer & Secretary |
Charles Goodwin | President, CEO & Director |
David Turkaly | JMP Securities |
Matthew O'Brien | Piper Sandler & Co. |
Kyle Bauser | Colliers Securities |
Matthew Hewitt | Craig-Hallum |
George Cleveland | RENN Capital Group |
Good afternoon, ladies and gentlemen, and welcome to the Third Quarter of Fiscal Year 2021 Earnings Conference Call for Apyx Medical Corporation. [Operator Instructions]. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.
Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the Risk Factors section of our most recent annual report on Form 10-K filed with the Securities and Exchange Commission as well as our most recent 10-Q filing. Such factors may be updated from time to time in our filings with the SEC, which are available on our website.